These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 27619839

  • 1. VEGF-loaded microsphere patch for local protein delivery to the ischemic heart.
    Rodness J, Mihic A, Miyagi Y, Wu J, Weisel RD, Li RK.
    Acta Biomater; 2016 Nov; 45():169-181. PubMed ID: 27619839
    [Abstract] [Full Text] [Related]

  • 2. Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel.
    Rufaihah AJ, Johari NA, Vaibavi SR, Plotkin M, Di Thien DT, Kofidis T, Seliktar D.
    Acta Biomater; 2017 Jan 15; 48():58-67. PubMed ID: 27756647
    [Abstract] [Full Text] [Related]

  • 3. MRI study of cryoinjury infarction in pig hearts: i. Effects of intrapericardial delivery of bFGF/VEGF embedded in alginate beads.
    Yang Y, Gruwel ML, Dreessen de Gervai P, Sun J, Jilkina O, Gussakovsky E, Kupriyanov V.
    NMR Biomed; 2012 Jan 15; 25(1):177-88. PubMed ID: 21960023
    [Abstract] [Full Text] [Related]

  • 4. Controlled release of vascular endothelial growth factor from spray-dried alginate microparticles in collagen-hydroxyapatite scaffolds for promoting vascularization and bone repair.
    Quinlan E, López-Noriega A, Thompson EM, Hibbitts A, Cryan SA, O'Brien FJ.
    J Tissue Eng Regen Med; 2017 Apr 15; 11(4):1097-1109. PubMed ID: 25783558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
    Shin SH, Lee J, Lim KS, Rhim T, Lee SK, Kim YH, Lee KY.
    J Control Release; 2013 Feb 28; 166(1):38-45. PubMed ID: 23262200
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
    Shin SH, Lee J, Ahn DG, Lee KY.
    Pharm Res; 2013 Aug 28; 30(8):2157-65. PubMed ID: 23686375
    [Abstract] [Full Text] [Related]

  • 9. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
    Cittadini A, Monti MG, Petrillo V, Esposito G, Imparato G, Luciani A, Urciuolo F, Bobbio E, Natale CF, Saccà L, Netti PA.
    Eur J Heart Fail; 2011 Dec 28; 13(12):1264-74. PubMed ID: 22045926
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction.
    Deng B, Shen L, Wu Y, Shen Y, Ding X, Lu S, Jia J, Qian J, Ge J.
    J Biomed Mater Res A; 2015 Mar 28; 103(3):907-18. PubMed ID: 24827141
    [Abstract] [Full Text] [Related]

  • 12. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J, Zhan Y, Wang Y, Han D, Tao B, Luo Z, Ma S, Wang Q, Li X, Fan L, Li C, Deng H, Cao F.
    Acta Biomater; 2018 Oct 15; 80():154-168. PubMed ID: 30218777
    [Abstract] [Full Text] [Related]

  • 13. Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis.
    Choi DH, Subbiah R, Kim IH, Han DK, Park K.
    Small; 2013 Oct 25; 9(20):3468-76. PubMed ID: 23585380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor release from alginate microspheres under simulated physiological compressive loading and the effect on human vascular endothelial cells.
    Li Q, Hou T, Zhao J, Xu J.
    Tissue Eng Part A; 2011 Jul 25; 17(13-14):1777-85. PubMed ID: 21341993
    [Abstract] [Full Text] [Related]

  • 18. VEGF165A microsphere therapy for myocardial infarction suppresses acute cytokine release and increases microvascular density but does not improve cardiac function.
    Uitterdijk A, Springeling T, van Kranenburg M, van Duin RW, Krabbendam-Peters I, Gorsse-Bakker C, Sneep S, van Haeren R, Verrijk R, van Geuns RJ, van der Giessen WJ, Markkula T, Duncker DJ, van Beusekom HM.
    Am J Physiol Heart Circ Physiol; 2015 Aug 01; 309(3):H396-406. PubMed ID: 26024685
    [Abstract] [Full Text] [Related]

  • 19. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats.
    Salimath AS, Phelps EA, Boopathy AV, Che PL, Brown M, García AJ, Davis ME.
    PLoS One; 2012 Aug 01; 7(11):e50980. PubMed ID: 23226440
    [Abstract] [Full Text] [Related]

  • 20. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
    Ruvinov E, Leor J, Cohen S.
    Biomaterials; 2011 Jan 01; 32(2):565-78. PubMed ID: 20889201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.